CETP inhibitors

Details for Australian Patent Application No. 2005270058 (hide)

Owner Merck & Co., Inc.

Inventors Thompson, Christopher F.; Napolitano, Joann M.; Taylor, Gayle E.; Hunt, Julianne A.; Li, Hong; Quraishi, Nazia; Deng, Qiaolin; Smith, Cameron J.; Lu, Zhijian; Chen, Yi-Heng; Ali, Amjad; Sinclair, Peter J.; Dowst, Adrian A.

Agent Spruson & Ferguson

Pub. Number AU-B-2005270058

PCT Pub. Number WO2006/014413

Priority 60/585,274 02.07.04 US; 60/646,103 21.01.05 US

Filing date 1 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 23 April 2009

International Classifications

C07D 263/20 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/4166 (2006.01)

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 233/32 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 263/22 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/24 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 285/10 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/014413 Priority application(s): WO2006/014413

23 April 2009 Application Accepted

  Published as AU-B-2005270058

20 August 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270059-Antifungal polypeptides

2005270049-Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors